Quick Answer
CorMedix Inc. reported Net Income of $163.06 million for fiscal year 2025.
CorMedix Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $163.06M | +1009.4% |
| 2024 | -$17.93M | +61.3% |
| 2023 | -$46.34M | -56.0% |
| 2022 | -$29.70M | -5.3% |
| 2021 | -$28.21M | -28.1% |
| 2020 | -$22.03M | -34.0% |
| 2019 | -$16.43M | +38.8% |
| 2018 | -$26.83M | +18.7% |
| 2017 | -$33.01M | -33.9% |
| 2016 | -$24.64M | -35.5% |
| 2015 | -$18.19M | +11.1% |
| 2014 | -$20.45M | -123.9% |
| 2013 | -$9.13M | -170.2% |
| 2012 | -$3.38M | +49.6% |
| 2011 | -$6.71M | +38.5% |
| 2010 | -$10.91M | -34.3% |
| 2009 | -$8.12M | +9.7% |
| 2008 | -$9.00M | -24.3% |
| 2007 | -$7.24M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $108.56M | +4009.6% | +447.5% |
| June 30, 2025 | $19.83M | +240.1% | -4.0% |
| March 31, 2025 | $20.64M | +242.7% | +843.4% |
| September 30, 2024 | -$2.78M | +71.5% | +80.4% |
| June 30, 2024 | -$14.15M | -25.5% | +2.2% |
| March 31, 2024 | -$14.47M | -36.9% | -48.5% |
| September 30, 2023 | -$9.74M | -42.2% | +13.6% |
| June 30, 2023 | -$11.27M | -48.2% | -6.7% |
- CorMedix Inc. showed an increase of +1009.4% in Net Income compared to the prior fiscal year.
- Over the 2007–2025 period, CorMedix Inc.’s net income has grown by 2352.9% (from -$7.24 million to $163.06 million).
- The most recent figure is from CorMedix Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: